ARTICLE | Deals
Under Bain’s ownership, Mitsubishi Tanabe to seek deals, growth in Japan
Japanese pharma’s parent chooses $3.4B buyout to create PE-backed standalone company
February 7, 2025 9:38 PM UTC
A private equity buyout will separate Mitsubishi Tanabe from its longtime parent, putting the financial strength of Bain Capital behind the Japanese pharma as it seeks to execute on a strategy to strengthen R&D capacity and drive growth.
Mitsubishi Chemical Group Corp. (Tokyo:4188) had been signaling for months that it was seeking a partner willing to invest in its pharma unit’s innovative programs. On Friday, the company said Bain Capital would acquire Mitsubishi Tanabe Pharma Corp. for about ¥510 billion ($3.4 billion)...